Amphastar Pharmaceuticals Operating Margin 2012-2024 | AMPH

Current and historical operating margin for Amphastar Pharmaceuticals (AMPH) over the last 10 years. The current operating profit margin for Amphastar Pharmaceuticals as of September 30, 2024 is 25.15%.
Amphastar Pharmaceuticals Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $0.72B $0.21B 29.60%
2024-06-30 $0.71B $0.23B 32.26%
2024-03-31 $0.68B $0.21B 31.31%
2023-12-31 $0.65B $0.20B 30.54%
2023-09-30 $0.60B $0.18B 30.07%
2023-06-30 $0.54B $0.13B 24.21%
2023-03-31 $0.52B $0.12B 22.97%
2022-12-31 $0.50B $0.11B 21.69%
2022-09-30 $0.48B $0.09B 19.42%
2022-06-30 $0.48B $0.10B 20.17%
2022-03-31 $0.46B $0.08B 18.02%
2021-12-31 $0.44B $0.07B 15.98%
2021-09-30 $0.41B $0.05B 11.86%
2021-06-30 $0.38B $0.03B 7.29%
2021-03-31 $0.37B $0.01B 3.80%
2020-12-31 $0.35B $0.01B 3.14%
2020-09-30 $0.34B $0.01B 2.37%
2020-06-30 $0.33B $0.01B 1.80%
2020-03-31 $0.33B $0.01B 3.06%
2019-12-31 $0.32B 0 0.00%
2019-09-30 $0.33B $0.00B 0.61%
2019-06-30 $0.33B $0.00B 0.92%
2019-03-31 $0.32B $-0.00B -0.32%
2018-12-31 $0.30B $-0.01B -2.71%
2018-09-30 $0.27B $-0.01B -4.53%
2018-06-30 $0.25B $-0.02B -7.29%
2018-03-31 $0.24B $-0.01B -5.39%
2017-12-31 $0.24B $-0.00B -0.83%
2017-09-30 $0.24B $-0.01B -2.05%
2017-06-30 $0.25B $0.00B 1.60%
2017-03-31 $0.25B $0.01B 4.74%
2016-12-31 $0.26B $0.02B 5.88%
2016-09-30 $0.27B $0.03B 12.69%
2016-06-30 $0.27B $0.02B 8.96%
2016-03-31 $0.25B $0.00B 1.57%
2015-12-31 $0.25B $-0.01B -2.78%
2015-09-30 $0.23B $-0.03B -12.12%
2015-06-30 $0.23B $-0.03B -14.10%
2015-03-31 $0.22B $-0.02B -10.36%
2014-12-31 $0.21B $-0.02B -8.53%
2014-09-30 $0.21B $-0.01B -3.81%
2014-06-30 $0.21B 0 0.00%
2014-03-31 $0.22B $0.01B 5.83%
2013-12-31 $0.23B $0.02B 7.39%
2013-09-30 $0.23B $0.07B 29.07%
2013-06-30 $0.23B $0.12B 54.67%
2013-03-31 $0.21B $0.16B 75.83%
2012-12-31 $0.20B $0.20B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.097B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00